These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 23825310)

  • 21. Host T cells are the main producers of IL-17 within the central nervous system during initiation of experimental autoimmune encephalomyelitis induced by adoptive transfer of Th1 cell lines.
    Lees JR; Iwakura Y; Russell JH
    J Immunol; 2008 Jun; 180(12):8066-72. PubMed ID: 18523270
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Influenza virus infection exacerbates experimental autoimmune encephalomyelitis disease by promoting type I T cells infiltration into central nervous system.
    Chen Q; Liu Y; Lu A; Ni K; Xiang Z; Wen K; Tu W
    J Autoimmun; 2017 Feb; 77():1-10. PubMed ID: 28341037
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Mnk1 and 2 are dispensable for T cell development and activation but important for the pathogenesis of experimental autoimmune encephalomyelitis.
    Gorentla BK; Krishna S; Shin J; Inoue M; Shinohara ML; Grayson JM; Fukunaga R; Zhong XP
    J Immunol; 2013 Feb; 190(3):1026-37. PubMed ID: 23269249
    [TBL] [Abstract][Full Text] [Related]  

  • 24. A Tolerogenic Artificial APC Durably Ameliorates Experimental Autoimmune Encephalomyelitis by Directly and Selectively Modulating Myelin Peptide-Autoreactive CD4
    Wan X; Pei W; Shahzad KA; Zhang L; Song S; Jin X; Wang L; Zhao C; Shen C
    J Immunol; 2018 Aug; 201(4):1194-1210. PubMed ID: 29987163
    [TBL] [Abstract][Full Text] [Related]  

  • 25. IL-9 is important for T-cell activation and differentiation in autoimmune inflammation of the central nervous system.
    Li H; Nourbakhsh B; Cullimore M; Zhang GX; Rostami A
    Eur J Immunol; 2011 Aug; 41(8):2197-206. PubMed ID: 21674475
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mesenchymal stem cells differentially modulate effector CD8+ T cell subsets and exacerbate experimental autoimmune encephalomyelitis.
    Glenn JD; Smith MD; Calabresi PA; Whartenby KA
    Stem Cells; 2014 Oct; 32(10):2744-55. PubMed ID: 24911892
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of the MHC class II transactivator in class II expression and antigen presentation by astrocytes and in susceptibility to central nervous system autoimmune disease.
    Stüve O; Youssef S; Slavin AJ; King CL; Patarroyo JC; Hirschberg DL; Brickey WJ; Soos JM; Piskurich JF; Chapman HA; Zamvil SS
    J Immunol; 2002 Dec; 169(12):6720-32. PubMed ID: 12471103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Loss of IFN-gamma enables the expansion of autoreactive CD4+ T cells to induce experimental autoimmune encephalomyelitis by a nonencephalitogenic myelin variant antigen.
    Sabatino JJ; Shires J; Altman JD; Ford ML; Evavold BD
    J Immunol; 2008 Apr; 180(7):4451-7. PubMed ID: 18354166
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Regulatory lymphocytes are key factors in MHC-independent resistance to EAE.
    Marín N; Mecha M; Espejo C; Mestre L; Eixarch H; Montalban X; Álvarez-Cermeño JC; Guaza C; Villar LM
    J Immunol Res; 2014; 2014():156380. PubMed ID: 24868560
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Depletion of CD4+ CD25+ regulatory T cells confers susceptibility to experimental autoimmune encephalomyelitis (EAE) in GM-CSF-deficient Csf2-/- mice.
    Ghosh D; Curtis AD; Wilkinson DS; Mannie MD
    J Leukoc Biol; 2016 Oct; 100(4):747-760. PubMed ID: 27256565
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T-bet is essential for Th1-mediated, but not Th17-mediated, CNS autoimmune disease.
    O'Connor RA; Cambrook H; Huettner K; Anderton SM
    Eur J Immunol; 2013 Nov; 43(11):2818-23. PubMed ID: 23878019
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mycobacterium bovis bacille Calmette-Guérin infection in the CNS suppresses experimental autoimmune encephalomyelitis and Th17 responses in an IFN-gamma-independent manner.
    Lee J; Reinke EK; Zozulya AL; Sandor M; Fabry Z
    J Immunol; 2008 Nov; 181(9):6201-12. PubMed ID: 18941210
    [TBL] [Abstract][Full Text] [Related]  

  • 33. B cells promote induction of experimental autoimmune encephalomyelitis by facilitating reactivation of T cells in the central nervous system.
    Pierson ER; Stromnes IM; Goverman JM
    J Immunol; 2014 Feb; 192(3):929-39. PubMed ID: 24367024
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The effect of calcitriol and all-trans retinoic acid on T-bet, IFN-γ, GATA3 and IL-4 genes expression in experimental autoimmune encephalomyelitis.
    Parastouei K; Solaymani-Mohammadi F; Shiri-Shahsavar MR; Chahardoli R; Nasl-Khameneh AM; Zarandi MB; Ghotloo S; Saboor-Yaraghi AA
    APMIS; 2020 Nov; 128(11):583-592. PubMed ID: 32865844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. IL-10 is involved in the suppression of experimental autoimmune encephalomyelitis by CD25+CD4+ regulatory T cells.
    Zhang X; Koldzic DN; Izikson L; Reddy J; Nazareno RF; Sakaguchi S; Kuchroo VK; Weiner HL
    Int Immunol; 2004 Feb; 16(2):249-56. PubMed ID: 14734610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. SLAM-SAP signaling promotes differentiation of IL-17-producing T cells and progression of experimental autoimmune encephalomyelitis.
    Huang YH; Tsai K; Ma C; Vallance BA; Priatel JJ; Tan R
    J Immunol; 2014 Dec; 193(12):5841-53. PubMed ID: 25362182
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Interferon-β regulates dendritic cell activation and migration in experimental autoimmune encephalomyelitis.
    Pennell LM; Fish EN
    Immunology; 2017 Nov; 152(3):439-450. PubMed ID: 28646573
    [TBL] [Abstract][Full Text] [Related]  

  • 38. EAE mediated by a non-IFN-γ/non-IL-17 pathway.
    Kroenke MA; Chensue SW; Segal BM
    Eur J Immunol; 2010 Aug; 40(8):2340-8. PubMed ID: 20540117
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Thymic stromal lymphopoietin deficiency attenuates experimental autoimmune encephalomyelitis.
    Eckhardt J; Döbbeler M; König C; Kuczera K; Kuhnt C; Ostalecki C; Zinser E; Mak TW; Steinkasserer A; Lechmann M
    Clin Exp Immunol; 2015 Jul; 181(1):51-64. PubMed ID: 25753260
    [TBL] [Abstract][Full Text] [Related]  

  • 40. IL-7Rα on CD4
    Azizi G; Van den Broek B; Ishikawa LLW; Naziri H; Yazdani R; Zhang GX; Ciric B; Rostami A
    J Neuroinflammation; 2024 Oct; 21(1):253. PubMed ID: 39380064
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.